tiprankstipranks
Trending News
More News >
Allogene Therapeutics Inc (ALLO)
NASDAQ:ALLO
US Market

Allogene Therapeutics (ALLO) Cash flow

Compare
1,567 Followers

Allogene Therapeutics Cash Flow

ALLO's free cash flow for Q3 2025 was $-29.93M. For the 2025 fiscal year, ALLO's free cash flow was decreased by $38.26M and operating cash flow was $-29.69M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -200.30M$ -237.73M$ -220.52M$ -184.81M$ -115.09M
Investing Cash Flow
$ 75.69M$ 163.29M$ 106.16M$ 163.66M$ -505.12M
Financing Cash Flow
$ 116.67M$ 95.69M$ 2.95M$ 11.96M$ 633.59M
End Cash Position
$ 85.51M$ 93.45M$ 72.20M$ 183.61M$ 192.80M
Free Cash Flow
$ -200.99M$ -239.25M$ -225.71M$ -206.26M$ -181.05M
Currency in USD

Allogene Therapeutics Cash Flow